SecBot SecBot
ANALYST-UPGRADE

ABBV

AbbVie Inc.
BULLISH
Impact 1/10
Horizonmonths Processed6mo ago SECanalyst-ABBV-canaccor-20260421
Canaccord Genuity initiates coverage on ABBV at Buy
Actionable Insight ▲ Bullish

Bullish initiation from a below-average accuracy firm into an already crowded consensus and weakening EPS trends offers limited incremental conviction. With earnings in 3 days and negative institutional flows, the upgrade lacks strong corroboration, treat as noise.

DirectionBullish
Confidencemedium
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$205.12
T+0 close · Apr 21, 2026 · via day close
Latest settled
+24.02%
T+60 · $254.39
Vs SPY
+17.12%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 21 $205.12entry
  2. T+1 · 7mo ago −2.25%α −3.27% · $200.50
  3. T+5 · 7mo ago −3.62%α −4.71% · $197.69
  4. T+20 · 6mo ago +2.09%α −2.82% · $209.41
  5. T+60 · 4mo ago +24.02%α +17.12% · $254.39
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Canaccord Genuity initiates coverage on AbbVie (ABBV) with a Buy rating and $262 price target, implying 28.6% upside from the current $203.71. The firm’s accuracy is 47% (722/1538), below the 57% average among 15 tracked firms. Consensus is overwhelmingly bullish: 28 of 29 analysts rate ABBV Buy or equivalent (97% Buy-rated), with a mean PT of $249. EPS estimates are declining: 30-day revisions show 7 down, 0 up for current year. Earnings due in 3 days. Insider selling totaled $2.57M in March. Institutional activity mixed: Norges Bank exited, Renaissance Technologies trimmed. Short ratio at 57.1%. Contrarian call from a below-average accuracy firm into weakening EPS trends and negative institutional flows limits signal strength.

Impact Score

Base Score
1/7
LLM Adjustment
+0
Final Score
1/10

Consensus & Targets

Buy / Strong Buy
28 (72%)
Hold
11
Sell / Strong Sell
0
Total Analysts
29
Mean PT
$249.00
Median PT
$249.00
High PT
$299.00
Low PT
$184.00
Current Price
$203.71
Implied Upside
+22.2%

Of 29 analysts, 28 rate ABBV as Buy or Strong Buy (97%), and 1 as Hold. No Sell ratings. The consensus is strongly aligned and heavily skewed toward positive sentiment, with 7 Strong Buys and 21 Buys.

The consensus price target mean and median are both $249, with a high of $299 and low of $184. At $203.71, the stock has 22.4% implied upside to the mean. Canaccord’s $262 PT is 5.2% above the mean and 53.9% above the low, placing it in the top quartile of targets.

Recent Analyst Activity

DateFirmActionRatingPrice Target
2026-04-21Canaccord GenuityinitiateBuy$262.00
2026-04-10GuggenheimmaintainBuy$249.00
2026-04-08Cantor FitzgeraldmaintainOverweight$240.00
2026-02-25RBC CapitalinitiateOutperform$260.00
2026-02-20BarclaysinitiateOverweight$275.00
2026-02-18Piper SandlermaintainOverweight$299.00
2026-02-17Freedom BrokermaintainBuy$260.00
2026-02-05UBSmaintainNeutral$230.00
2026-02-05Evercore ISI GroupmaintainOutperform$228.00
2026-02-05Morgan StanleymaintainOverweight$270.00

Over the past 30 days, there has been 1 upgrade and 0 downgrades. EPS revisions are negative: 7 down, 0 up over the past 30 days for current-year estimates. Forward EPS estimates have declined from $14.54 to $14.33 (0y) and $16.12 to $16.09 (+1y), signaling weakening sentiment despite high ratings.

Firm Track Record: Canaccord Genuity

Canaccord Genuity accuracy: 47% on 1538 calls | avg return: 3%

Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.

FirmAccuracyCallsAvg Returnvs Average
JP Morgan100%4/47.5%top tier
HSBC100%3/34.5%top tier
Cantor Fitzgerald89%8/99.6%top tier
Wells Fargo75%3/40%top tier
BMO Capital71%5/74.2%top tier
Evercore ISI Group67%2/34.8%top tier
Piper Sandler67%4/67.5%top tier
Morgan Stanley67%6/94%top tier
Citigroup63%5/85.9%top tier
UBS60%3/5-1.2%above average

Canaccord Genuity has a 47% accuracy rate (722 correct out of 1538 rated calls), below the average of the 15 tracked firms (57%). Their average return on rated stocks is 3%, below top-tier firms like Cantor Fitzgerald (9.6%) and JP Morgan (7.5%). Among peers, only B of A Securities (20%) has a lower accuracy.

Earnings Estimates

Next earnings: Apr 24, 2026

PeriodEPS Est.EPS RangeRevenueRevisions (7d)
0q$2.76$2.57 to $3.08$14.7B↑0 ↓0
+1q$3.76$3.59 to $4.02$16.8B↑2 ↓0
0y$14.33$13.97 to $15.00$67.1B↑0 ↓0
+1y$16.09$14.95 to $17.42$72.5B↑1 ↓0

Cross-Platform Signals

Insider Trades (90d)
0 buys / 2 sells
Institutional
NORGES BANK: new
Institutional
Cullen Capital Management, LLC: add (60.1%)
Institutional
RENAISSANCE TECHNOLOGIES LLC: exit (-100%)
Short Interest
Short: 1,533,215 | Exempt: 3,439 | TRF Vol: 2,683,911 | Short Ratio: 57.1% | Off-exchange volume (dark pool + OTC)

Insiders sold $2.57M in March (Purdue David Ryan: $1.22M; Siatis Perry C: $1.35M). Institutions show divergence: Norges Bank fully exited a $5.87B position, and Renaissance Technologies trimmed by 52.7%, while Cullen Capital added 60.1%. Short interest is high at 57.1% short ratio, suggesting elevated bearish positioning despite analyst optimism.

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

22 reports on ABBV

Performance horizon

6 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +27.21% at T+60 after the Apr 29, 2026 report. 6 of 8 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $293.89 Now $294.55 +0.22% settles Dec 9
  2. Nov 2, 202614d ago 8-K Neutral 2/10 Entry $286.00 Now $294.55 +2.99% settles Dec 2
  3. Oct 30, 202617d ago 8-K Bullish 6/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  4. Oct 29, 202619d ago Court Ruling Bullish 7/10 Entry $294.89 Now $294.55 −0.12% settles Nov 30
  5. Oct 16, 20264w ago Institutional Cluster Bullish 4/10 Entry $282.68 to $294.55 Now $294.55 +4.20% ▲ +4.20% +7.66% vs SPY
  6. Oct 15, 20264w ago 8-K Neutral 2/10 Entry $285.42 to $295.03 Now $294.55 +3.20% ▲ +3.37% +4.53% vs SPY
  7. Oct 5, 20266w ago 8-K Neutral 4/10 Entry $265.06 to $289.60 Now $294.55 +11.12% ▲ +9.26% +12.16% vs SPY
  8. Sep 28, 20267w ago Court Ruling Neutral 2/10 Entry $263.29 to $286.39 Now $294.55 +11.87% ▲ +8.77% +8.06% vs SPY
  9. Sep 14, 20269w ago Court Ruling Neutral Not scored Entry $261.43 to $272.69 Now $294.55 +12.67% ▲ +4.30% +1.33% vs SPY
  10. Sep 3, 202610w ago 8-K Neutral 4/10 Entry $260.21 to $262.82 Now $294.55 +13.20% ▲ +1.00% +2.19% vs SPY
Showing 10 of 22

US Market Status

Market Closed · Opens Wed (11h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 21, 2026